Archives of Industrial Biotechnology

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +1 (629)348-3199

Editorial - Archives of Industrial Biotechnology (2024) Volume 8, Issue 6

Synthetic biology tools for industrial strain development.

Sahar Parsa *

Department of Biotechnology, Sharif University of Technology, Iran

*Corresponding Author:
Sahar Parsa
Department of Biotechnology, Sharif University of Technology, Iran
E-mail: parsa.sahar@sharif.edu

Received: 02-Dec-2024, Manuscript No. AAAIB-24-154687; Editor assigned: 03-Dec-2024, PreQC No AAAIB-24-154687 (PQ) Reviewed:17-Dec-2024, QC No. AAAIB-24-154687 Revised:24-Dec-2024, Manuscript No. AAAIB-24-154687 (R); Published:30-Dec-2024, DOI:10.35841/aaaib-8.6.239

Citation: Parsa S. Synthetic biology tools for industrial strain development. Arch Ind Biot. 2024;8(6):239

Visit for more related articles at Archives of Industrial Biotechnology

Introduction

Synthetic biology has revolutionized biotechnology by providing a robust platform for designing and engineering biological systems with unprecedented precision. Industrial strain development, a cornerstone of biomanufacturing, has greatly benefited from synthetic biology tools. These tools enable the systematic modification of microbial and eukaryotic organisms to optimize their performance for industrial applications, including pharmaceuticals, biofuels, food, and materials production. This article explores the key synthetic biology tools that have transformed industrial strain development [1].

Genome editing technologies like CRISPR-Cas systems, TALENs, and ZFNs have been pivotal in strain development. CRISPR-Cas9, in particular, allows targeted gene deletions, insertions, or modifications with high precision. This capability facilitates the creation of strains with enhanced metabolic efficiency, resistance to stress, or improved production of desired compounds. For instance, CRISPR-based editing has been used to enhance lipid production in Yarrowia lipolytica for biofuel applications [2].

Synthetic biology enables the redesign of metabolic pathways for increased flux toward desired products. Pathway engineering involves the introduction or removal of metabolic genes, optimization of enzyme levels, and balancing co-factor usage. Tools like synthetic promoters, ribosome-binding sites, and pathway optimization software allow fine-tuning of gene expression, enabling the efficient conversion of raw materials into valuable products [3].

Synthetic gene circuits are modular constructs that control gene expression in response to specific signals. These circuits can be used to implement logic gates, feedback loops, and biosensors within industrial strains. For example, toggle switches and oscillators have been integrated into microbial systems to dynamically regulate the production of biochemicals, reducing metabolic burden and improving yield [4].

Advances in genomics, transcriptomics, proteomics, and metabolomics provide a holistic understanding of cellular networks. Coupled with bioinformatics tools and machine learning algorithms, omics data guides the rational design of strains by identifying bottlenecks in metabolic pathways or stress response mechanisms. Computational tools like COBRA (Constraint-Based Reconstruction and Analysis) are widely used for metabolic modeling and strain optimization [5].

Synthetic biology tools integrate high-throughput screening techniques with directed evolution to identify optimal strains rapidly. Techniques like fluorescence-activated cell sorting (FACS) and droplet microfluidics enable the screening of millions of variants. Coupled with error-prone PCR or DNA shuffling, directed evolution generates diversity, from which the most promising strains are selected [6].

Automation and robotics have significantly accelerated the strain development process. Platforms like BioXp and Biofoundries use synthetic biology tools to automate DNA assembly, transformation, and strain evaluation. These systems reduce human error and enable rapid prototyping, ensuring faster time-to-market for industrial bioprocesses [7].

ALE uses controlled environmental pressures to evolve strains with desired traits over successive generations. Synthetic biology enhances ALE by designing selective pressures and monitoring evolutionary trajectories. For example, ALE has been used to improve tolerance to toxic substrates, enhancing the scalability of bioprocesses. The concept of minimal genomes, where unnecessary genes are removed to create streamlined strains, has been realized through synthetic biology. Organisms like Escherichia coli and Mycoplasma mycoides have been reduced to their essential genes, allowing precise metabolic control and reducing competition for cellular resources [8].

While most tools are initially developed for model organisms like E. coli or yeast, synthetic biology has expanded into non-model organisms. Engineering extremophiles, for example, has opened avenues for bioprocesses operating under harsh industrial conditions, such as high salinity, temperature, or pH. Despite these advancements, synthetic biology faces challenges like unpredictable interactions within engineered systems, regulatory hurdles, and public acceptance. Addressing biosafety and biosecurity concerns is crucial for broader adoption. Moreover, developing synthetic biology tools for economically important, but less studied, organisms requires continued innovation [9].

The integration of synthetic biology with artificial intelligence (AI), advanced imaging, and real-time monitoring promises a new era of industrial strain development. AI-driven predictive models and closed-loop feedback systems will enable adaptive control of engineered strains, optimizing performance during production [10].

Conclusion

Synthetic biology tools have become indispensable for industrial strain development, offering unparalleled capabilities for designing and optimizing biological systems. As the field continues to evolve, these tools will drive innovation in sustainable manufacturing, ensuring economic viability while addressing global challenges such as energy scarcity and climate change. The seamless integration of synthetic biology into industrial biotechnology will undoubtedly shape the future of biomanufacturing.

References

  1. Jullesson D, David F, Pfleger B, et al. Impact of synthetic biology and metabolic engineering on industrial production of fine chemicals. Biotechnol Adv. 2015;33(7):1395-402.

    2. Indexed at, Google Scholar, Cross Ref

  2. Katz L, Chen YY, Gonzalez R, et al. Synthetic biology advances and applications in the biotechnology industry: a perspective. J Ind Microbiol Biotechnol. 2018;45(7):449-61.

    3. Indexed at, Google Scholar, Cross Ref

  3. Jensen MK, Keasling JD. Recent applications of synthetic biology tools for yeast metabolic engineering. FEMS Yeast Res. 2015;15(1):1-0.

    4. Indexed at, Google Scholar, Cross Ref

  4. Kelwick R, MacDonald JT, Webb AJ, et al. Developments in the tools and methodologies of synthetic biology. Front Bioeng Biotechnol. 2014;2:60.

    5. Indexed at, Google Scholar, Cross Ref

  5. Tang WL, Zhao H. Industrial biotechnology: tools and applications. Biotechnol Healthc. 2009;4(12):1725-39.

    6. Indexed at, Google Scholar, Cross Ref

  6. Chen Y, Banerjee D, Mukhopadhyay A, et al. Systems and synthetic biology tools for advanced bioproduction hosts. Curr Opin Biotechnol. 2020;64:101-9.

    7. Indexed at, Google Scholar, Cross Ref

  7. Larroudé M, Rossignol T, Nicaud JM, et al. Synthetic biology tools for engineering Yarrowia lipolytica. Biotechnol Adv. 2018;36(8):2150-64.

    8. Indexed at, Google Scholar, Cross Ref

  8. Wagner JM, Alper HS. Synthetic biology and molecular genetics in non-conventional yeasts: current tools and future advances. Fungal Genet Biol. 2016;89:126-36.

    9. Indexed at, Google Scholar, Cross Ref

  9. Markham KA, Alper HS. Synthetic biology expands the industrial potential of Yarrowia lipolytica. Trends Biotechnol. 2018;36(10):1085-95.

    10. Indexed at, Google Scholar, Cross Ref

  10. Keasling JD. Synthetic biology and the development of tools for metabolic engineering. Metab Eng. 2012;14(3):189-95.

    11. Indexed at, Google Scholar, Cross Ref

Get the App